Top 3 Genomics Stocks to Consider for Your Portfolio
Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.
Pacific Biosciences ( PACB ) Upgraded to Buy: Here's Why
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y
PacBio posts a narrower Q3 loss and margin gains, but shares fall as revenues dip amid softer instrument demand.
Pacific Biosciences of California ( PACB ) Reports Q3 Loss, Lags Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +25.00% and -3.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences ( PACB ) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Pacific Biosciences (PACB), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday - Astera Labs ( NASDAQ:ALAB ) , Arcosa ( NYSE:ACA )
U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Friday. Shares of Cloudflare, Inc. ( NYSE:NET ) rose sharply during Friday's session after the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance above estimates.
Cathie Wood Just Dumped $7.4 Million Worth Of Palantir And AMD Shares - Here's What Ark Is Buying Instead - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Thursday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc. ( NASDAQ:PLTR ) , Advanced Micro Devices Inc. ( NASDAQ:AMD ) , Pacific Biosciences of California Inc. ( NASDAQ:PACB ) , and DoorDash Inc. ( NASDAQ:DASH ) .
Pacific Biosciences of California ( PACB ) Stock Drops Despite Market Gains: Important Facts to Note
Pacific Biosciences of California (PACB) concluded the recent trading session at $1.97, signifying a -5.74% move from its prior day's close.
Pacific Biosciences of California ( PACB ) Stock Moves -4.04%: What You Should Know
Pacific Biosciences of California (PACB) reached $1.9 at the closing of the latest trading day, reflecting a -4.04% change compared to its last close.
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
PACB unveils new SPRQ-Nx chemistry to cut sequencing costs and boost multiomic features on Revio and Vega.
Pacific Biosciences of California ( PACB ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.59, marking a -1.85% move from the previous day.
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
PACB's Q2 beat, expanding Revio and Vega systems and growing clinical traction highlight its innovation-led recovery despite longer purchasing cycles.
PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell
PACB expands seqWell partnership to enhance its sequencing workflow offerings with a new multiplexing kit.
Why Pacific Biosciences of California ( PACB ) Outpaced the Stock Market Today
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.52, marking a +2.01% move from the previous day.
Applied Materials, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Applied Mat ( NASDAQ:AMAT ) , Bed Bath & Beyond ( NYSE:BBBY )
U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday. Shares of Applied Materials Inc ( NASDAQ:AMAT ) fell sharply in pre-market trading y after the company announced that the U.S. Commerce Department expanded export restrictions that will ...
Pacific Biosciences of California ( PACB ) Rises Higher Than Market: Key Facts
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.29, indicating a +1.57% shift from the previous trading day.
Why Pacific Biosciences of California ( PACB ) Dipped More Than Broader Market Today
In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.17, denoting a -7.14% move from the preceding trading day.
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.
Pacific Biosciences of California ( PACB ) Reports Q2 Loss, Beats Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +27.78% and +9.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Tandem Diabetes Care, Inc. ( TNDM ) Reports Q2 Loss, Beats Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -20.00% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Stay Ahead of the Game With Pacific Biosciences ( PACB ) Q2 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top-and-bottom-line estimates for Pacific Biosciences (PACB), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Pacific Biosciences of California ( PACB ) Suffers a Larger Drop Than the General Market: Key Insights
Pacific Biosciences of California (PACB) reached $1.54 at the closing of the latest trading day, reflecting a -6.1% change compared to its last close.
Pacific Biosciences of California ( PACB ) Stock Sinks As Market Gains: What You Should Know
Pacific Biosciences of California (PACB) reached $1.39 at the closing of the latest trading day, reflecting a -6.71% change compared to its last close.
Pacific Biosciences of California ( PACB ) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.5, representing a +1.35% change from its previous close.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.
Pacific Biosciences ( PACB ) Upgraded to Strong Buy: Here's What You Should Know
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Pacific Biosciences of California ( PACB ) Stock Sinks As Market Gains: What You Should Know
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.24, representing a -3.88% change from its previous close.
Why Is Steris ( STE ) Down 1.8% Since Last Earnings Report?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pacific Biosciences of California ( PACB ) Outperforms Broader Market: What You Need to Know
Pacific Biosciences of California (PACB) closed at $1.18 in the latest trading session, marking a +1.72% move from the prior day.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset sales cycle delays and drive 2025 growth.
All You Need to Know About Pacific Biosciences ( PACB ) Rating Upgrade to Buy
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates
Despite strong Service and other revenues, PACB reports soft first-quarter 2025 results partly due to lower Revio system shipments.
Pacific Biosciences of California ( PACB ) Reports Q1 Loss, Tops Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 21.05% and 6.15%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Palantir Technologies Inc. PLTR, Advanced Micro Devices Inc. AMD, and Shopify Inc. SHOP. Ark Invest made a notable move by selling shares of Palantir Technologies Inc.
Pacific Biosciences of California ( PACB ) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.11, marking a -1.77% move from the previous day.
Pacific Biosciences of California ( PACB ) Flat As Market Gains: What You Should Know
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.17, marking no change from the previous day.
Sequencing Company PacBio Cuts Costs Amid Uncertainty Around NIH Funding And New Tariffs - Pacific Biosciences ( NASDAQ:PACB )
PacBio reported $36.9 million in Q1 revenue, beating consensus, with record consumable sales and steady Revio system pull-through. Company to cut $45-$50 million in annualized costs by year-end amid NIH funding uncertainty and macroeconomic pressures. Feel unsure about the market's next move?
Simply Good Foods, Pacific Biosciences of California, Kura Sushi, Delta Air Lines And Other Big Stocks Moving Higher On Wednesday - Akso Health ( NASDAQ:AHG ) , Anglogold Ashanti ( NYSE:AU )
U.S. stocks were higher, with the Dow Jones index surging over 300 points on Wednesday. Shares of The Simply Good Foods Company SMPL rose sharply during Wednesday's session following better-than-expected quarterly results.
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Absci ( NASDAQ:ABSI ) , Amgen ( NASDAQ:AMGN )
On Friday, March 21, 2025, the Cathie Wood-led Ark Invest made some notable trades, including significant buys and sells. Ark Invest's fund bought Iridium Communications Inc. IRDM, Beam Therapeutics Inc. BEAM, Pacific Biosciences of California Inc. PACB and Absci Corp ABSI, while selling Illumina ...
Pacific Biosciences of California ( PACB ) Advances While Market Declines: Some Information for Investors
Pacific Biosciences of California (PACB) reachead $1.26 at the closing of the latest trading day, reflecting a +0.8% change compared to its last close.
Here's Why You Should Retain PacBio Stock in Your Portfolio Now
PACB continues to deliver growth from its unique technologies amid macroeconomic concerns.
Pacific Biosciences of California ( PACB ) Increases Yet Falls Behind Market: What Investors Need to Know
In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.22, denoting a +1.67% change from the preceding trading day.
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday - Beam Therapeutics ( NASDAQ:BEAM ) , Airbnb ( NASDAQ:ABNB )
U.S. stocks were mostly lower, with the Dow Jones falling around 100 points on Friday. Shares of The Goodyear Tire & Rubber Company GT rose sharply during Friday's session after the company reported better-than-expected quarterly financial results.
PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall
Despite strong Service and other revenues, PacBio reports soft fourth-quarter 2024 results partly due to lower Revio system shipments.
Pacific Biosciences of California ( PACB ) Reports Q4 Loss, Tops Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California ( PACB ) Stock Sinks As Market Gains: Here's Why
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.44, representing a -1.37% change from its previous close.
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
MENLO PARK, Calif., Feb. 03, 2025 ( GLOBE NEWSWIRE ) -- PacBio ( NASDAQ: PACB ) , a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company's new Global Head of Sales & Service.
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service - Pacific Biosciences ( NASDAQ:PACB )
MENLO PARK, Calif., Feb. 03, 2025 ( GLOBE NEWSWIRE ) -- PacBio PACB, a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company's new Global Head of Sales & Service.
Pacific Biosciences of California ( PACB ) Stock Moves -1.18%: What You Should Know
Pacific Biosciences of California (PACB) closed at $1.67 in the latest trading session, marking a -1.18% move from the prior day.
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
